Course of pattern-reversed visual evoked cortical potentials in 30 eyes after bony orbital decompression in dysthyroid optic neuropathy
INTRODUCTION
In up to 8.6% of patients with Graves' orbitopathy (GO), the clinical course is complicated by dysthyroid optic neuropathy (DON). 1 2 Although the exact mechanisms underlying DON still require illumination, the optic nerve with its vascular supply is vulnerable to compression especially in the orbital apex. 3 Secondary to inflammative swelling of extraocular muscles and orbital soft tissue, apical orbital crowding may lead to altered blood supply and impairment of axonal transport, resulting in functional impairment of the optic nerve. 4 5 As DON can be better correlated to periorbital swelling and impairment of motility than to lid retraction or proptosis, the diagnosis may be obscured in the absence of these clinical entities. 4 6 Clinical signs for DON (decreased vision, an afferent pupillary defect or funduscopic abnormalities such as papilloedema) should result in prompt therapeutic intervention. To enhance diagnostic precision, conduction of visual evoked cortical potentials (VECP) may be accompanied by orbital imaging.
2e8 Pattern-reversal VECP remains a valuable tool in the diagnosis and follow-up of DON as the disease is significantly associated with P100 amplitude loss and delayed deflection. 2 8e14 In addition, pattern-reversal VECP is able to identify even subclinical courses of DON with high sensitivity. 12 Established treatment for DON includes intravenous administration of corticosteroids and bony decompression of the orbit. Several surgical approaches with one-to four-wall orbital delamination have been considered with variable efficacy to reverse congestive proptosis and optic nerve impairment. 15 Previous studies using VECP to monitor DON during courses of steroid or radiation treatment showed partial remission of DON, but only there are only a few patient reports on VECP development after orbital bony decompression.
With the intention of selectively focusing on the restoration of optic nerve function as reflected by pattern-reversal VECP, we analysed retrospectively the clinical courses from 30 eyes of 15 patients with DON using pattern-reversal VECP before and after bilateral bony orbital three-wall decompression. 16 
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MATERIAL AND METHODS
We retrospectively analysed clinical outcomes, and the courses and results of VECP in 15 non-consecutive GO patients (n¼30 eyes) with DON undergoing orbital decompression. Inclusion criteria were symptoms of DON (at least one of the following signs): an otherwise unexplained visual loss in at least one eye, presence of a (relative) afferent pupillary deficit (RAPD), colour desaturation and a pathological VECP. Another prerequisite was a normalised thyroid hormone level as assessed by serological quantification of free triiodothyronine (fT3) and tetraiodothyronine (fT4).
The study's intervention consisted of bilateral bony three-wall orbital decompression using a combined coronar and anterior approach with osteotomy and resection of the lateral, medial and inferior orbital walls, followed by dissection of the medial and posterior ethmoidal cells. Furthermore, orbital fat resection was performed after slitting of the periorbita. 16 Postoperative systemic steroid treatment with fluocortolone was administered at a cumulative dose of 1.55 g over 6 weeks starting with 1 mg/kg body weight per day orally.
Visual acuity (VA) assessment was performed on the day before VECP measurement within 1 week prior to decompression surgery, using standardised tests of Landolt optotypes at a distance of 5 m according to DIN 58220. Values were converted to the logarithm of the minimum angle of resolution (logMAR) for statistical analyses. Vision was compared between values at VECP examinations, as well as between preoperative and last examination results. Significant vision improvement was assumed when vision increased by at least two lines. VECP conductance was followed by mydriatic ophthalmoscopy. At the same time, Hertel's exophthalmometry and biomicroscopic slit lamp examination with ophthalmoscopy were performed. Accordingly, clinical activity scores (CAS) and modified NOSPECS scores were recorded as described elsewhere. 17 Presence of an RAPD was assayed using the swinging-flashlight test at symmetrical test and background luminances. Patients with documented corneal pathology (stippled or eroded corneal epithelium) were excluded from the study.
VECP assessment was in full accordance with the International Society for Clinical Electrophysiology of Vision (ISCEV) standards. 18 Cortical responses to reversing full-field checkerboard stimulations were measured using gold cup electrodes (Oz-Fz) and earlobe clip electrodes (Schuler GmbH, Freiburg, Germany) connected to a Jaeger/Toennies multi-linear vision unit (Hoechberg, Germany). Ten20 EEG paste (D.O. Weaver & Co., Aurora, Colorado, USA) was used as a conductive gel after alcoholic skin-scouring to achieve impedances below 5 U. Checkerboard squares of four different sizes were consecutively presented in a darkened testing chamber on a 25320 cm rectangular monitor screen with a fixation point in the centre at a distance of 100 cm. Monocular stimulation was adopted in all investigations. Rectangular stimulation square sizes were 13.7, 27.5, 60 and 120 min of angle (arcmin) at each conduction level. Mean monitor luminance was 50 cd/m 2 and the checkerboardreversal rate was set to 2 Hz, thereby achieving a contrast of 80% between white and black checks. Signals were filtered at 1e100 Hz, amplified and averaged from 200 cycles with 1% artefact tolerance. Latencies and amplitudes of the first positive through (N75 to P100) as well as of the second negative through (P100 to N140) were used for evaluation. Values of recordings before and after orbital decompression were analysed and compared with results obtained from an age-matched control group. P100 latency deterioration was defined as either prolongation of previously pathological values or a newly pathological latency in any of the four different checkerboard pattern sizes not registered during preoperative testing. Upper latency limits were calculated by adding two standard deviations to mean values from healthy age-matched subjects in our laboratory for each checkerboard pattern size. Upper latency limits were 129 ms at 13.7 arcmin, 125.5 ms at 27.5 arcmin, 124 ms at 60 arcmin and 126 ms at 120 arcmin.
Statistical analysis
Statistical evaluation was performed using a two-sided Student t test (level of significance 5%) after verification of parametric distribution using the KolmogoroveSmirnov index. Values in the text represent mean6SD unless otherwise indicated.
RESULTS Patients
Thirty eyes of 15 patients with GO were included into the study of which 93% were female. All patients were previously treated either by radioiodine therapy (n¼4) or by thyroidectomy (n¼11) and had progressive GO despite previous administration of at least one cycle of systemic steroid therapy. Furthermore, bilateral orbital irradiation was performed in 12 patients in the past without achieving sufficient remission. Because in most cases pretreatment was not coordinated by our centre, both orbital irradiation and steroid therapy were administered at variable treatment and dosing regimes. 19 A history of smoking was present in 87% of patients. One patient received octreotide immunosuppression because of psoriasis comorbidity. Additional patient characteristics are shown in table 1.
The mean interval between initial diagnosis of GO and orbital decompression was 1.161.0 years. CAS before decompression was 762 and NOSPECS was 962 (mean6SD).
VA
During the postoperative period, mean logMAR VA increased significantly by 2.4 lines (from 0.3860.25 immediately before surgery to 0.1460.1 after 30613 months). The mean VA of figure 1) . After decompression surgery, all eyes maintained or improved vision during follow-up. Fifty per cent of patients significantly gained vision by two or more lines. Figure 2 further itemises vision responses to orbital decompression in three baseline decimal vision groups. Clearly, patients with low baseline vision preferentially profited from surgery. Vision gain of up to six lines in two eyes and a mean gain of 4.5 lines were evident in this subgroup of eight eyes. Furthermore, stabilisation or improvement evident both in the intermediate (0.5e0.32) as well as in the good baseline vision groups (figure 2).
Exophthalmometry
Hertel's exophthalmometry revealed a statistically significant reduction of 6.463 mm 30613 months after decompression, from 22.463.3 mm before surgery to 16.162.6 mm (p<0.0001).
VECP amplitudes
During the VECP observation period of 12611 months, mean VECP-P100 amplitudes of 30 eyes increased significantly by 4.4, 2.6, 2.6 and 1.9 mV at 13.7, 27.5, 60 and 120 arcmin stimulation checkerboard size, respectively, corresponding to increases of 92%, 43%, 44% and 31%, respectively (p¼0.002, 0.019, 0.012 and 0.064, respectively). P100 amplitudes generated by large patterns of 120 arcmin did not change after decompression. Figure 3 illustrates median courses of amplitudes in the respective checksize groups over the observation period; table 2 shows P100 amplitude and latencies before and after decompression in detail.
VECP latencies
P100 latencies after decompression surgery were not statistically significantly different from the recordings prior to decompression. The total incidence of pathological VECP P100 latency values decreased after decompression surgery. Median latency outcome after 12611 months depended on the stimulation pattern size (figure 4). While decreased latencies were seen at 13.7 arcmin pattern size, prolongations were evident at 27.5 and 120 arcmin. Median P100 latencies at 60 arcmin remained stable but tended to increase during follow-up. Figure 5 shows the latency courses for the baseline vision groups before and after decompression. All vision groups developed latency prolongation when stimulated by large pattern sizes (120 arcmin). In the intermediate vision group, patients initially and after decompression surgery had prolonged latencies during testing with small check-sizes, with a tendency to normalise after therapy. New postoperative latency deterioration was immediately evident in all vision groups, always restricted to the smallest pattern size not affected in the preoperative examination (data not shown).
Worsening of latencies assigned to stimulation pattern size was evident in four patients of the low and intermediate vision groups, as well as in three patients in the high baseline vision group. One patient developed latency deterioration in all four preoperatively pathological check-sizes, despite maintaining unchanged vision during follow-up.
DISCUSSION
Here we report on the beneficial results of bony orbital decompression to prevent irreversible vision loss due to DON. Efficient reduction of proptosis was associated with gain of VA and Figure 1 Logarithm of the minimum angle of resolution (logMAR) vision before and after decompression surgery. All patients gained vision or remained stable during follow-up of 30613 months after therapy. VA, visual acuity. improvement of pattern-evoked VECPamplitudes after 12 months in our group of patients showing persistent active disease despite previous systemic steroid therapy. To our knowledge, this is the largest study implementing VECP conductance to monitor optic nerve function before and after bony orbital decompression.
All patients were previously treated either by radioiodine or thyroidectomy and had normal serum fT3 and fT4 values at the time of decompression surgery as well as during follow-up. All patients previously received systemic steroids and 13 patients underwent additional orbital irradiation without sufficient or definite remission of GO prior to decompression. Pretreatment was not always coordinated by our clinic and variations in prior treatment regimes were thus unavoidable. However, the circumstances leading to DON in these patients were not subject of the study.
Bilateral surgical intervention was performed by the same surgeon with a standardised dosing regimen of postoperative steroids. The bilateral approach was chosen even in cases with asymmetrical optic nerve function because of relatively symmetric proptosis on both eyes in all patients. Monitoring of DON in response to therapy has been achieved using different techniques of pattern-and flash-evoked VECP. 9 10 Tsaloumas et al compared pattern-and flash-evoked VECP during radiation and decompression therapy and concluded that there were no substantial differences between the techniques.
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However pattern-evoked VECP may be affected by patient compliance, media opacity or blurred vision primarily impairing amplitude potentials, while latencies remain unaffected or may be compromised to a much lesser extent as long as retinal luminance remains unaffected. 11 20 Although our patients underwent systemic steroid treatment, significant cataract formation during the VECP follow-up period was not observed. Ongoing visual rehabilitation over the longer clinical follow-up period further underlines that cataract formation is unlikely to have affected VECP results in our study. Potential changes in retinal luminance caused by altered pupil diameters following orbital surgery secondary to intraoperative trauma to pupillomotoric nerve fibres remain unlikely and should not appear on a regular basis. Frequently occurring postoperative complications included strabism with diplopia and hypoesthesia of the facial skin. 16 21 While Tsaloumas and co-workers reported on immediate mean latency recovery 2 weeks after orbital decompression in seven eyes with DON using pattern-reversed stimuli, Setälä and associates observed indiscriminate mean flash-evoked cortical response latencies after 7 years of follow-up in seven patients. 10 11 This is in line with our findings after a mean follow-up of 10 months: latencies did not reveal significant regeneration and even deteriorated in some patients after bony orbital decompression. Vision gain was not necessarily associated with restoration of P100 latency: three of five patients with postoperative full vision (100%) simultaneously revealed pathological P100 latencies in at least one check-size conduction group. Patient distribution into preoperative vision groups helped to align postoperative vision outcome, but did not further help to identify correlations of preoperative clinical courses with postoperative P100 latency results. Neither the duration of Graves' disease before decompression nor clinical activity scores, preoperative history of radioiodine therapy, surgical thyroidectomy or orbital irradiation revealed consistent correlation with latencies before or after decompression surgery.
Our observation of newly appearing latency defects after decompression surgery raises the question of whether other neuro-ophthalmic disorders or mechanisms underlying DON (which preoperatively were not represented by latency deterioration) may have led to axonal conduction defects at the end of follow-up. Although drastic latency defects due to demyelination frequently seen in encephalomyelitis disseminata were not evident in our study, DON may amplify the potential of other compressive optic neuropathies to impair both amplitudes and latencies of the VECP. 22 Comparably, an underlying (compressive) vascular mechanism observable in ischaemic opticoneuropathies with limited latency defects and imposing amplitude loss has to be considered. In conclusion, the early interpretation of Wijngaarde and van Lith in suspecting circulatory disturbance through mechanical pressure on small or damaged vessel walls based on their VECP results in DON are further supported by our study.
